REPORTS

Global Healthcare Distribution Services Market Size study, by Type (Pharmaceutical Product Distribution Services, Medical Device Distribution Services and Biopharmaceutical Product Distribution Services) End-user (Retail Pharmacies, Hospital Pharmacies and other End Users) and Regional Forecasts 2019-2026

Publishing Date : 04 Jan 2019 Report Code : Bizwit_1724 Pages : 200 Category : Healthcare and Pharma
Description

Global Healthcare Distribution Services Market is valued approximately USD 718.50 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.50 % over the forecast period 2019-2026. Healthcare distribution Services market includes moving and storing pharmaceutical goods from plants to wholesalers, hospitals and patients. Also, the healthcare companies must comply with stringent public regulation as pharmaceutical products should be available in useable shapes to ensure their safety records. Further, high incidences of chronic diseases and increasing uptake of biopharmaceuticals has led the adoption of healthcare distribution services across the forecast period. As per the Pharmaceutical Research and Manufacturing Association (PhRMA) about half of the world's R&D in pharmaceuticals of about $75 billion are conducted in the U.S. As per the source, the biopharmaceuticals account for $1.3 trillion in economic output that represent 4% of the total U.S. economy. This total economic impact includes $558 billion in revenue from biopharmaceuticals business. However, pricing pressures impedes the growth of the market over the forecast period of 2019-2026. The regional analysis of global Healthcare Distribution Services market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of a large number of pharmaceutical and biotechnology companies and medical device manufacturers. Also, the dominance of healthcare distribution market is witnessed due to the increasing government focus on generic drugs, incidence of chronic diseases, rising demand for biologics and specialty drugs. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate over the forecast period 2019-2026. Factors such as rising number of pharmaceutical and biotechnology companies, the implementation of stringent regulations to enhance the quality and reliability of pharmaceutical drugs and expanding pharmaceutical industries would create lucrative growth prospects for the Healthcare Distribution Services market across Asia-Pacific region. Major market player included in this report are: McKesson Corporation Cardinal Health, Inc. AmerisourceBergen Corporation Owens & Minor, Inc. Morris & Dickson Co. L.L.C. Curascript Specialty Distribution FFF Enterprises, Inc. Medline Industries Attain Med, Inc. Dakota Drug The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Type: Pharmaceutical Product Distribution Services Medical Device Distribution Services Biopharmaceutical Product Distribution Services By End-user: Retail Pharmacies Hospital Pharmacies Other End Users By Region: North America U.S. Canada Europe UK Germany Asia Pacific China India Japan Latin America Brazil Mexico Rest of the World Furthermore, years considered for the study are as follows: Historical year - 2016, 2017 Base year - 2018 Forecast period - 2019 to 2026 Target Audience of the Global Healthcare Distribution Services Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value-Added Resellers (VARs) Third-party knowledge providers Investment bankers Investors

Table of Figures

Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Key Trends 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion) 1.3.1. Healthcare Distribution Services Market, by Type, 2016-2026 (USD Billion) 1.3.2. Healthcare Distribution Services Market, by End-user, 2016-2026 (USD Billion) 1.3.3. Healthcare Distribution Services Market, by Region, 2016-2026 (USD Billion) 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Healthcare Distribution Services Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Industry Evolution 2.2.2. Scope of the Study 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Healthcare Distribution Services Market Dynamics 3.1. See Saw Analysis 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Healthcare Distribution Services Market Industry Analysis 4.1. Porter's 5 Force Model 4.1.1. Bargaining Power of Buyers 4.1.2. Bargaining Power of Suppliers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter's 5 Force Model 4.2. PEST Analysis 4.2.1. Political Scenario 4.2.2. Economic Scenario 4.2.3. Social Scenario 4.2.4. Technological Scenario 4.3. Key Buying Criteria (On Demand) 4.4. Regulatory Framework (On Demand) 4.5. Investment Vs Adoption Scenario (On Demand) 4.6. Analyst Recommendation & Conclusion Chapter 5. Global Healthcare Distribution Services Market, by Type 5.1. Market Snapshot 5.2. Market Performance - Potential Model 5.3. Healthcare Distribution Services Market, Sub Segment Analysis 5.3.1. Pharmaceutical Product Distribution Services 5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 5.3.2. Medical Device Distribution Services 5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 5.3.3. Biopharmaceutical Product Distribution Services 5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion) 5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) Chapter 6. Global Healthcare Distribution Services Market, by End User 6.1. Market Snapshot 6.2. Market Performance - Potential Model 6.3. Healthcare Distribution Services Market, Sub Segment Analysis 6.3.1. Retail Pharmacies 6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.3.2. Hospital Pharmacies 6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.3.3. Other End Users 6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) Chapter 7. Global Healthcare Distribution Services Market, by Regional Analysis 7.1. Healthcare Distribution Services Market, Regional Market Snapshot (2016-2026) 7.2. North America Healthcare Distribution Services Market Snapshot 7.2.1. U.S. 7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.2.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.2.1.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.2.2. Canada 7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.2.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.2.2.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.3. Europe Healthcare Distribution Services Market Snapshot 7.3.1. U.K. 7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.3.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.3.1.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.3.2. Rest of Europe 7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.3.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.3.2.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.4. Asia Pacific Healthcare Distribution Services Market Snapshot 7.4.1. China 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.4.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.4.1.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.4.2. India 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.4.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.4.2.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.4.3. Japan 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.4.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.4.3.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.4.4. Rest of Asia Pacific 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.4.4.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.4.4.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.5. Latin America Healthcare Distribution Services Market Snapshot 7.5.1. Brazil 7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.5.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.5.1.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.5.2. Mexico 7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.5.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.5.2.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.6. Rest of The World 7.6.1. Middle East and Africa 7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 7.6.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 7.6.1.3. End-user breakdown estimates & forecasts, 2016-2026 (USD Billion) Chapter 8. Competitive Intelligence 8.1. Company Market Share (Subject to Data Availability) 8.2. Top Market Strategies 8.3. Company Profiles 8.3.1. McKesson Corporation 8.3.1.1. Overview 8.3.1.2. Financial (Subject to Data Availability) 8.3.1.3. Product Summary 8.3.1.4. Recent Developments 8.3.2. Cardinal Health, Inc. 8.3.3. AmerisourceBergen Corporation 8.3.4. Owens & Minor, Inc. 8.3.5. Morris & Dickson Co. L.L.C. 8.3.6. Curascript Specialty Distribution 8.3.7. FFF Enterprises, Inc. 8.3.8. Medline Industries 8.3.9. Attain Med, Inc. 8.3.10. Dakota Drug Chapter 9. Research Process 9.1. Research Process 9.1.1. Data Mining 9.1.2. Analysis 9.1.3. Market Estimation 9.1.4. Validation 9.1.5. Publishing 9.1.6. Research Assumption